The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).

Source:http://linkedlifedata.com/resource/pubmed/id/16221474

Download in:

View as

General Info

PMID
16221474